Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Insulet (PODD) Other financing activities (2020)

Insulet filings provide 2 years of Other financing activities readings, the most recent being $500000.0 for Q4 2020.

On a quarterly basis, Other financing activities changed N/A to $500000.0 in Q4 2020 year-over-year; TTM through Sep 2022 was $500000.0, a 214.68% increase, with the full-year FY2023 number at -$300000.0, changed N/A from a year prior.
Other financing activities hit $500000.0 in Q4 2020 for Insulet, up from -$936000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $500000.0 in Q4 2020 to a low of $500000.0 in Q4 2020.